Grassley, Wyden Invite Drugmakers to Testify at Feb. 29 Pricing Hearing

Drug Industry Daily
A A
Leaders of the Senate Finance Committee invited seven leading drug companies to testify in an upcoming hearing on drug pricing — and hinted that they will take a more aggressive approach if the drugmakers decline the invitation.

To View This Article:

Login

Subscribe To Drug Industry Daily